Cover Image
市場調查報告書

眼睛黏彈性劑 (OVD):醫療設備的開發平台分析

Ophthalmic Viscoelastic Devices (OVD) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 361019
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
眼睛黏彈性劑 (OVD):醫療設備的開發平台分析 Ophthalmic Viscoelastic Devices (OVD) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年08月03日 內容資訊: 英文 35 Pages
簡介

本報告提供全球眼科黏彈劑 (眼睛黏彈性劑:以下簡稱OVD)的市場上主要開發中產品及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,並彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 眼睛黏彈性劑 (OVD)的概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 臨床實驗中的開發中產品:各企業

  • 眼睛黏彈性劑 (OVD)的企業:各臨床實驗階段的開發中產品
  • 眼睛黏彈性劑 (OVD):各臨床實驗階段的開發中產品

第5章 眼睛黏彈性劑 (OVD):企業·產品概要

  • EyeKon Medical, Inc.
    • 開發中產品及進行中的臨床實驗概要

第6章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0405EPD

GlobalData's Medical Devices sector report, "Ophthalmic Viscoelastic Devices (OVD) - Medical Devices Pipeline Assessment, 2017" provides an overview of Ophthalmic Viscoelastic Devices (OVD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Viscoelastic Devices (OVD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Ophthalmic Viscoelastic Devices (OVD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Viscoelastic Devices (OVD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Viscoelastic Devices (OVD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Ophthalmic Viscoelastic Devices (OVD) Overview 5

3 Products under Development 6

  • 3.1 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Stage of Development 6
  • 3.2 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Segment 7
  • 3.3 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Territory 8
  • 3.4 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Regulatory Path 9
  • 3.5 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Estimated Approval Date 10

4 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products under Development by Companies 11

  • 4.1 Ophthalmic Viscoelastic Devices (OVD) Companies - Pipeline Products by Stage of Development 11
  • 4.2 Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Stage of Development 12

5 Ophthalmic Viscoelastic Devices (OVD) Companies and Product Overview 13

  • 5.1 EyeKon Medical Inc Company Overview 13
    • 5.1.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.2 Shanghai Haohai Biological Technology Co Ltd Company Overview 30
    • 5.2.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.3 Valeant Pharmaceuticals International Inc Company Overview 31
    • 5.3.1 Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31

6 Appendix 32

  • 6.1 Methodology 32
  • 6.2 About GlobalData 35
  • 6.3 Contact Us 35
  • 6.4 Disclaimer 35

List of Tables

1.1 List of Tables

  • Table 1: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Stage of Development 6
  • Table 2: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Segment 7
  • Table 3: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Territory 8
  • Table 4: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Regulatory Path 9
  • Table 5: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Estimated Approval Date 10
  • Table 6: Ophthalmic Viscoelastic Devices (OVD) Companies - Pipeline Products by Stage of Development 11
  • Table 7: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Stage of Development 12
  • Table 8: EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 13
  • Table 9: AcuGel Plus Viscoelastics - Product Status 14
  • Table 10: AcuGel Plus Viscoelastics - Product Description 14
  • Table 11: AcuGel SH Viscoelastics - Product Status 14
  • Table 12: AcuGel SH Viscoelastics - Product Description 15
  • Table 13: AcuGel Viscoelastics - Product Status 15
  • Table 14: AcuGel Viscoelastics - Product Description 15
  • Table 15: Acurus Gel - Product Status 16
  • Table 16: Acurus Gel - Product Description 16
  • Table 17: Acurus Gel Plus - Product Status 16
  • Table 18: Acurus Gel Plus - Product Description 17
  • Table 19: Acurus SH - Product Status 17
  • Table 20: Acurus SH - Product Description 17
  • Table 21: Cirrus Biogel Plus - Product Status 18
  • Table 22: Cirrus Biogel Plus - Product Description 18
  • Table 23: Cirrus Biogel SH - Product Status 18
  • Table 24: Cirrus Biogel SH - Product Description 19
  • Table 25: DR Gel - Product Status 19
  • Table 26: DR Gel - Product Description 19
  • Table 27: DR Gel Plus - Product Status 20
  • Table 28: DR Gel Plus - Product Description 20
  • Table 29: DR Gel SH - Product Status 20
  • Table 30: DR Gel SH - Product Description 21
  • Table 31: EyeCoat Plus Viscoelastic - Product Status 21
  • Table 32: EyeCoat Plus Viscoelastic - Product Description 21
  • Table 33: EyeCoat SH Viscoelastic - Product Status 22
  • Table 34: EyeCoat SH Viscoelastic - Product Description 22
  • Table 35: EyeCoat Viscoelastic - Product Status 22
  • Table 36: EyeCoat Viscoelastic - Product Description 23
  • Table 37: Isogel - Product Status 23
  • Table 38: Isogel - Product Description 23
  • Table 39: Isogel Plus - Product Status 24
  • Table 40: Isogel Plus - Product Description 24
  • Table 41: Isogel SH - Product Status 24
  • Table 42: Isogel SH - Product Description 25
  • Table 43: MD Gel - Product Status 25
  • Table 44: MD Gel - Product Description 25
  • Table 45: MD Gel Plus - Product Status 26
  • Table 46: MD Gel Plus - Product Description 26
  • Table 47: MD Gel SH - Product Status 26
  • Table 48: MD Gel SH - Product Description 27
  • Table 49: Suncoast Gel Viscoelastics - Product Status 27
  • Table 50: Suncoast Gel Viscoelastics - Product Description 27
  • Table 51: Suncoast Plus Viscoelastics - Product Status 28
  • Table 52: Suncoast Plus Viscoelastics - Product Description 28
  • Table 53: Suncoast SH Viscoelastics - Product Status 28
  • Table 54: Suncoast SH Viscoelastics - Product Description 29
  • Table 55: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 56: QST Gel - OVD - Product Status 30
  • Table 57: QST Gel - OVD - Product Description 30
  • Table 58: Valeant Pharmaceuticals International Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 59: Ophthalmic Viscosurgical Device - Product Status 31
  • Table 60: Ophthalmic Viscosurgical Device - Product Description 31
  • Table 61: Glossary 34

List of Figures

1.2 List of Figures

  • Figure 1: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Stage of Development 6
  • Figure 2: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Segment 7
  • Figure 3: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Territory 8
  • Figure 4: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Regulatory Path 9
  • Figure 5: Ophthalmic Viscoelastic Devices (OVD) - Pipeline Products by Estimated Approval Date 10
Back to Top